{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:42Z","timestamp":1791357282951,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00482-019-0373-3","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:17:38Z","timestamp":1557415058000},"page":"424-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy, tolerability and safety of cannabis-based medicines for cancer pain","Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit von Cannabispr\u00e4paraten bei Tumorschmerz"],"prefix":"10.1007","volume":"33","author":[{"given":"Winfried","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Fitzcharles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"issue":"Supplement_4","key":"373_CR1","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, ESMO Guidelines Committee (2018) Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol 29(Supplement_4):iv166\u2013iv191","journal-title":"Ann Oncol"},{"key":"373_CR2","volume-title":"Cancer pain relief","author":"World Health Organization (WHO)","year":"1986","unstructured":"World Health Organization (WHO) (1986) Cancer pain relief. WHO, Genf"},{"key":"373_CR3","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA (2017) Opioids for cancer pain\u2014An overview of Cochrane reviews. Cochrane Database Syst Rev 7:CD12592","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"373_CR4","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","volume":"6","author":"A Blake","year":"2017","unstructured":"Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O\u2019Hearn S (2017) A selective review of medical cannabis in cancer pain management. Ann Palliat Med 6(Suppl 2):S215\u2013S222","journal-title":"Ann Palliat Med"},{"key":"373_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.outlook.2017.08.012","volume":"66","author":"MB Vyas","year":"2018","unstructured":"Vyas MB, LeBaron VT, Gilson AM (2018) The use of cannabis in response to the opioid crisis: A review of the literature. Nurs Outlook 66:56\u201365","journal-title":"Nurs Outlook"},{"key":"373_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1049909111402318","volume":"28","author":"GT Carter","year":"2011","unstructured":"Carter GT, Flanagan AM, Earleywine M, Abrams DI, Aggarwal SK, Grinspoon L (2011) Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care 28:297\u2013303","journal-title":"Am J Hosp Palliat Care"},{"key":"373_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00482-018-0299-1","volume":"32","author":"M Karst","year":"2018","unstructured":"Karst M (2018) Cannabinoids in pain medicine. Schmerz 32:381\u2013396","journal-title":"Schmerz"},{"key":"373_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3747\/co.25.3983","volume":"25","author":"K Martell","year":"2018","unstructured":"Martell K, Fairchild A, LeGerrier B, Sinha R, Baker S, Liu H, Ghose A, Olivotto IA, Kerba M (2018) Rates of cannabis use in patients with cancer. Curr Oncol 25:219\u2013225","journal-title":"Curr Oncol"},{"key":"373_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","volume":"49","author":"L Bar-Lev Schleider","year":"2018","unstructured":"Bar-Lev Schleider L, Mechoulam R, Lederman V, Hilou M, Lencovsky O, Betzalel O, Shbiro L, Novack V (2018) Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med 49:37\u201343","journal-title":"Eur J Intern Med"},{"issue":"3","key":"373_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ejp.1147","volume":"22","author":"N Krcevski-Skvarc","year":"2018","unstructured":"Krcevski-Skvarc N, Wells C, H\u00e4user W (2018) Availability and approval of cannabis-based medicines for chronic pain management and palliative\/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Eur J Pain 22(3):440\u2013454","journal-title":"Eur J Pain"},{"key":"373_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ejp.1185","volume":"22","author":"MA Fitzcharles","year":"2018","unstructured":"Fitzcharles MA, Eisenberg E (2018) Medical cannabis: A forward vision for the clinician. Eur J Pain 22:485\u2013491","journal-title":"Eur J Pain"},{"key":"373_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00482-015-0085-2","volume":"30","author":"M M\u00fccke","year":"2016","unstructured":"M\u00fccke M, Carter C, Cuhls H, Pr\u00fc\u00df M, Radbruch L, H\u00e4user W (2016) Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety. Schmerz 30:25\u201336","journal-title":"Schmerz"},{"key":"373_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M17-0155","volume":"16","author":"SM Nugent","year":"2017","unstructured":"Nugent SM, Morasco BJ, O\u2019Neil ME et\u00a0al (2017) The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Ann Intern Med 16:319\u2013331","journal-title":"Ann Intern Med"},{"key":"373_CR14","first-page":"CD012182","volume":"3","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Phillips T, Radbruch L, Petzke F, H\u00e4user W (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 3:CD12182","journal-title":"Cochrane Database Syst Rev"},{"key":"373_CR15","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Open Med 3:e123\u2013e130","journal-title":"Open Med"},{"key":"373_CR16","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Green S (2011) Cochrane handbook for systematic reviews of interventions. http:\/\/handbook.cochrane.org\/ . Accessed 21 Dec 2018"},{"key":"373_CR17","first-page":"CD012638","volume":"7","author":"S Derry","year":"2017","unstructured":"Derry S, Wiffen PJ, Moore RA et al (2017) Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev 7:CD12638","journal-title":"Cochrane Database Syst Rev"},{"key":"373_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT et\u00a0al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J\u00a0Pain 9:105\u2013121","journal-title":"J Pain"},{"key":"373_CR19","volume-title":"Medical dictionary for regulatory activities. Version 19.1","author":"International Council for Harmonisation.","year":"2016","unstructured":"International Council for Harmonisation. (2016) Medical dictionary for regulatory activities. Version 19.1. www.meddra.org\/news-and-events\/news\/all-translationsmeddra-version-191-are-now-available . Accessed 8 Aug 2016"},{"key":"373_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","volume":"29","author":"R Schaefert","year":"2015","unstructured":"Schaefert R, Welsch P, Klose P, Sommer C, Petzke F, H\u00e4user W (2015) Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4\u00a0weeks duration. Schmerz 29:47\u201359","journal-title":"Schmerz"},{"key":"373_CR21","first-page":"15","volume-title":"Systematic reviews in pain research: Methodology refined","author":"RA Moore","year":"2008","unstructured":"Moore RA, Barden J, Derry S, McQuay HJ (2008) Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA (eds) Systematic reviews in pain research: Methodology refined. IASP Press, Seattle, pp\u00a015\u201324"},{"key":"373_CR22","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum, Hillsdale"},{"key":"373_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-013-0443-4","volume":"23","author":"PM Fayers","year":"2014","unstructured":"Fayers PM, Hays RD (2014) Don\u2019t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Qual Life Res 23:1\u20134","journal-title":"Qual Life Res"},{"key":"373_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","volume":"20","author":"TA Furukawa","year":"2005","unstructured":"Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N (2005) Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol 20:49\u201352","journal-title":"Int Clin Psychopharmacol"},{"key":"373_CR25","unstructured":"Review Manager (RevMan) (2014) Computer program, Version 5.3. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen"},{"key":"373_CR26","volume-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated march 2011)","author":"HJ Sch\u00fcnemann","year":"2011","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P (2011) Interpreting results and drawing conclusions. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated march 2011). The Cochrane Collaboration, London (available from http:\/\/handbook.cochrane.org )"},{"key":"373_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","volume":"66","author":"G Guyatt","year":"2013","unstructured":"Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P (2013) GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a\u00a0single outcome and for all outcomes. J\u00a0Clin Epidemiol 66:151\u2013157","journal-title":"J Clin Epidemiol"},{"key":"373_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2049463717710042","volume":"11","author":"MT Fallon","year":"2017","unstructured":"Fallon MT, Lux EA, McQuade R et al (2017) Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: Two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain 11:119\u2013133","journal-title":"Br J Pain"},{"key":"373_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","volume":"55","author":"AH Lichtman","year":"2018","unstructured":"Lichtman AH, Lux EA, McQuade R et al (2018) Results of a\u00a0double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain. J\u00a0Pain Symptom Manage 55:179\u2013188.e1","journal-title":"J Pain Symptom Manage"},{"key":"373_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D et al (2010) Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J\u00a0Pain Symptom Manage 39:167\u2013179","journal-title":"J Pain Symptom Manage"},{"key":"373_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S et al (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A\u00a0randomized, placebo-controlled, gradeddose trial. J\u00a0Pain 13:438\u2013449","journal-title":"J Pain"},{"key":"373_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cpt1978242223","volume":"24","author":"PR Jochimsen","year":"1978","unstructured":"Jochimsen PR, Lawton RL, VerSteeg K, Noyes R Jr (1978) Effect of benzopyranoperidine, a\u00a0delta-9-THC congener, on pain. Clin Pharmacol Ther 24:223\u2013227","journal-title":"Clin Pharmacol Ther"},{"key":"373_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cpt197518184","volume":"18","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Avery DA, Canter AC (1975) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18:84\u201389","journal-title":"Clin Pharmacol Ther"},{"key":"373_CR34","first-page":"139","volume":"15","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Baram DA, Canter AC (1975) Analgesic effect of delta-9-tetrahydrocannabinol. Clin Pharmacol Ther 15:139\u2013143","journal-title":"Clin Pharmacol Ther"},{"key":"373_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt1978234397","volume":"23","author":"M Staquet","year":"1978","unstructured":"Staquet M, Gantt C, Machin D (1978) Effect of a\u00a0nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 23:397\u2013401","journal-title":"Clin Pharmacol Ther"},{"key":"373_CR36","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00520-018-4154-9","volume":"26","author":"JG Turcotte","year":"2018","unstructured":"Turcotte JG, del Roc\u00edo Guillen N\u00fa\u00f1ez M, Flores-Estrad D, O\u00f1ate-Oca\u00f1a LF, Zatarain-Barr\u00f3n ZL, Barr\u00f3n A, Arrieta O (2018) The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: A\u00a0randomized, double-blind clinical trial. Support Care Cancer 26:3029\u20133038","journal-title":"Support Care Cancer"},{"key":"373_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2125.1974.tb00257.x","volume":"1","author":"BH Davies","year":"1974","unstructured":"Davies BH, Weatherstone RM, Graham JD, Griffiths RD (1974) A pilot study of orally administered \u2206(1)-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus. Br J Clin Pharmacol 1:301\u2013306","journal-title":"Br J Clin Pharmacol"},{"key":"373_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0003489415612801","volume":"125","author":"M C\u00f4t\u00e9","year":"2016","unstructured":"C\u00f4t\u00e9 M, Trudel M, Wang C, Fortin A (2016) Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: A randomized double-blind placebo-controlled trial. Ann Otol Rhinol Laryngol 125:317\u2013324","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"373_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","volume":"47","author":"ME Lynch","year":"2014","unstructured":"Lynch ME, Cesar-Rittenberg P, Hohmann AG (2014) A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J\u00a0Pain Symptom Manage 47:166\u2013173","journal-title":"J Pain Symptom Manage"},{"key":"373_CR40","volume-title":"Safety and efficacy of smoked cannabis for improving quality of life in advanced cancer patients","author":"Tetra Bio-Pharma","year":"2018","unstructured":"Tetra Bio-Pharma (2018) Safety and efficacy of smoked cannabis for improving quality of life in advanced cancer patients. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03339622 . Accessed 31 Dec 2018 (ClinicalTrials.gov Identifier: NCT03339622)"},{"key":"373_CR41","volume-title":"Inhaled cannabis versus fentanyl buccal tablets for management of breakthrough pain in cancer patients","author":"D Martinez","year":"2019","unstructured":"Martinez D (2019) Inhaled cannabis versus fentanyl buccal tablets for management of breakthrough pain in cancer patients. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02675842?term=02675842&rank=1 . Accessed 31 Dec 2018 (ClinicalTrials.gov Identifier: NCT02675842)"},{"key":"373_CR42","volume-title":"Sativex oromucosal spray","author":"GW Pharmaceuticals","year":"2018","unstructured":"GW Pharmaceuticals (2018) Sativex oromucosal spray. https:\/\/www.medicines.org.uk\/emc\/product\/602\/smpc . Accessed 6 Apr 2019"},{"key":"373_CR43","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","volume":"346","author":"A Moore","year":"2013","unstructured":"Moore A, Derry S, Eccleston C, Kalso E (2013) Expect analgesic failure; pursue analgesic success. BMJ 346:f2690","journal-title":"BMJ"},{"key":"373_CR44","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s00103-008-0648-9","volume":"51","author":"F Andersohn","year":"2008","unstructured":"Andersohn F, Garbe E (2008) Pharmacoepidemiological research with large health databases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:1134\u20131155","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"373_CR45","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","volume":"20","author":"J Aviram","year":"2017","unstructured":"Aviram J, Samuelly-Leichtag G (2017) Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials. Pain Physician 20:E755\u2013E796","journal-title":"Pain Physician"},{"issue":"Suppl 2","key":"373_CR46","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","volume":"6","author":"A Blake","year":"2017","unstructured":"Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O\u2019Hearn S (2017) A selective review of medical cannabis in cancer pain management. Ann Palliat Med 6(Suppl 2):S215\u2013S222","journal-title":"Ann Palliat Med"},{"key":"373_CR47","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","volume":"159","author":"E Stockings","year":"2018","unstructured":"Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L (2018) Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A\u00a0systematic review and meta-analysis of controlled and observational studies. Pain 159:1932\u20131954","journal-title":"Pain"},{"key":"373_CR48","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen F, M\u00fcller-Vahl K (2012) The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 109:495\u2013501","journal-title":"Dtsch Arztebl Int"},{"key":"373_CR49","first-page":"111","volume":"64","author":"GM Allan","year":"2018","unstructured":"Allan GM, Ramji J, Perry D, Ton J, Beahm NP, Crisp N, Dockrill B, Dubin RE, Findlay T, Kirkwood J, Fleming M, Makus K, Zhu X, Korownyk C, Kolber MR, McCormack J, Nickel S, No\u00ebl G, Lindblad AJ (2018) Simplified guideline for prescribing medical cannabinoids in primary care. Can Fam Physician 64:111\u2013120","journal-title":"Can Fam Physician"},{"key":"373_CR50","volume-title":"S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht heilbaren Krebserkrankung","author":"Deutsche Gesellschaft f\u00fcr Palliativmedizin","year":"2015","unstructured":"Deutsche Gesellschaft f\u00fcr Palliativmedizin (2015) S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht heilbaren Krebserkrankung. https:\/\/www.dgpalliativmedizin.de\/allgemein\/s3-leitlinie.html . Accessed 2 Jan 2019"},{"issue":"22","key":"373_CR51","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ejp.1297","volume":"2018","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user W, Finn DP, Kalso E, Krcevski-Skvarc N, Kress HG, Morlion B, Perrot S, Sch\u00e4fer M, Wells C, Brill S (2018) European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain 2018(22):1547\u20131564","journal-title":"Eur J Pain"}],"container-title":["Der Schmerz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-019-0373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-019-0373-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-019-0373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T18:59:48Z","timestamp":1663441188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-019-0373-3"}},"subtitle":["A\u00a0systematic review with meta-analysis of randomised controlled trials","Eine systematische \u00dcbersichtsarbeit mit Metaanalyse randomisierter, kontrollierter Studien"],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1007\/s00482-019-0373-3","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]},"assertion":[{"value":"9 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"W.\u00a0H\u00e4user was reimbursed for travel and accommodation fees by Bioevents for organising a\u00a0congress on controversies on cannabis-based medicines. He is the head of the steering committee of the European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. L.\u00a0Radbruch is the president of the Geram Society for Palliative care. P.\u00a0Welsch and P.\u00a0Klose have no academic conflict of interests to declare. M.-A.\u00a0Fitzcharles is the head of the steering committee of a\u00a0position statement of the Canadian Rheumatology Association (\u201cA\u00a0Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases\u201d). All authors declare that they have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}